68 related articles for article (PubMed ID: 475908)
1. [Automatic system for evaluation of the velocity of dissolution rate of solid dosage forms].
Zecchi V; Cini M; Rodriguez L; Magnani M
Boll Chim Farm; 1979 Mar; 118(3):168-75. PubMed ID: 475908
[No Abstract] [Full Text] [Related]
2. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
[No Abstract] [Full Text] [Related]
3. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
4. [Bioavailability of ampicillin preparations for internal use].
Zak AF; Batuashvili TA; Shchedrin VI
Antibiotiki; 1980 Jan; 25(1):24-8. PubMed ID: 7356297
[TBL] [Abstract][Full Text] [Related]
5. [Role of mass transfer processes in drug formulation].
Rácz I; Marton S; Antal I; Plachy J; Csóka G
Acta Pharm Hung; 1996 May; 66(3):105-10. PubMed ID: 8975536
[TBL] [Abstract][Full Text] [Related]
6. [Investigations in Bioavailability of resinates as peroral retard drug dosage forms. Part 1: Pharmaceutical availability of dihydrocodein-resinates (author's transl)].
Mühlenbruch B; Strauss H; Glaubitz H
Pharmazie; 1982 Mar; 37(3):200-3. PubMed ID: 7100242
[TBL] [Abstract][Full Text] [Related]
7. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
[TBL] [Abstract][Full Text] [Related]
8. [Theory and practice in design of gastrointestinal DDS].
Nakano M
Nihon Rinsho; 1989 Jun; 47(6):1249-54. PubMed ID: 2769986
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation.
Arancibia A; González G; Icarte A; Arancibia M; Arancibia P
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):97-100. PubMed ID: 3557736
[TBL] [Abstract][Full Text] [Related]
10. Per-oral controlled release dosage form of theophylline using soybean protein.
Machida Y; Tokumura T; Nagai T
Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the accuracy of different types of dissolution rate methods.
Bolhuis GK; Lerk CF; Zuurman K
Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
[No Abstract] [Full Text] [Related]
12. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
13. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
Tomassini L; Naplatanova D
Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
[No Abstract] [Full Text] [Related]
14. Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man.
Bates TR; Pieniaszek HJ; Sequeira JA; Rasmussen JE
Arch Dermatol; 1977 Mar; 113(3):302-6. PubMed ID: 843096
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the rate of dissolution and absorption of opipramol from solid oral forms.
Kanarkowski R; Wichliński LM
Mater Med Pol; 1985; 17(2):85-7. PubMed ID: 4079473
[No Abstract] [Full Text] [Related]
16. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation.
Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D
Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310
[TBL] [Abstract][Full Text] [Related]
17. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
[TBL] [Abstract][Full Text] [Related]
18. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
Chakrabarti S; Belpaire F; Moerman E
Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
[TBL] [Abstract][Full Text] [Related]
19. Potassium absorption from sustained release tablets.
Graffner C; Sjögren J
Acta Pharm Suec; 1971 Mar; 8(1):13-8. PubMed ID: 5575869
[No Abstract] [Full Text] [Related]
20. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.
Katori N; Aoyagi N; Terao T
Pharm Res; 1995 Feb; 12(2):237-43. PubMed ID: 7784339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
